JOCELYN HARRINGTON: Open Payments
NPI 1427381441 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,009 in 52 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $22 · 2025 $1,009
Food & beverage: $1,009
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 15 | $223 |
| AstraZeneca Pharmaceuticals LP | 10 | $214 |
| Novartis Pharmaceuticals Corporation | 7 | $131 |
| Ionis Pharmaceuticals, Inc. | 3 | $76 |
| Pharming Healthcare, Inc. | 3 | $66 |
| Amgen Inc. | 3 | $58 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| GENZYME CORPORATION | 1 | $28 |
| PFIZER INC. | 1 | $27 |
Products named: NUCALA, TEZSPIRE, AIRSUPRA, DAWNZERA, TRELEGY ELLIPTA, RUCONEST, FASENRA, DUPIXENT.
Industry payments across NY — which companies pay providers there.
